<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30850" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Urinary Incontinence</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Leslie</surname>
            <given-names>Stephen W.</given-names>
          </name>
          <aff>Creighton University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tran</surname>
            <given-names>Linh N.</given-names>
          </name>
          <aff>Kaweah Delta Health Care District</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Puckett</surname>
            <given-names>Yana</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Stephen Leslie declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Linh Tran declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yana Puckett declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>8</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30850.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Urinary incontinence is the involuntary leakage of urine. This condition is prevalent in&#x000a0;older adults but can also affect younger adults and significantly impacts both health and quality of life. The&#x000a0;5 main types include stress, urge, mixed, overflow, and functional incontinence. Possible treatments include lifestyle adjustments, physical therapy, pelvic floor exercises, fluid management strategies, prompted voiding, biofeedback, catheters (intermittent or permanent), pads, pharmaceuticals, botulinum toxin injections, sacral neuromodulation, bedside suction devices, and&#x000a0;numerous procedures, including male and female slings, artificial sphincters, and prostate surgery.</p>
        <p>This activity reviews the&#x000a0;different types of urinary incontinence, effective screening practices, and evidence-based management strategies.&#x000a0;Participants gain comprehensive knowledge of the latest diagnostic techniques and treatment modalities, enabling them to provide improved patient care.&#x000a0;Clinicians also learn about the psychosocial aspects of the condition and how to address them, enhancing their ability to support patients holistically. This activity also&#x000a0;highlights the role of the interprofessional team in the care of patients with urinary incontinence,&#x000a0;leading to better clinical outcomes and improved quality of life for&#x000a0;individuals affected by urinary incontinence.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate&#x000a0;the etiologies of the various types of urinary incontinence.</p></list-item><list-item><p>Identify the key components in the evaluation of urinary incontinence.</p></list-item><list-item><p>Assess&#x000a0;the management options available for the various types of urinary incontinence.</p></list-item><list-item><p>Implement&#x000a0;interprofessional team strategies for screening and treating patients with urinary incontinence to improve health and quality of life outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30850&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30850">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30850.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Urinary incontinence, the involuntary leakage of urine, is a common condition among older individuals, particularly those in nursing homes, but it can also affect younger adults of both sexes. This condition significantly impacts patient health and quality of life.&#x000a0;The prevalence of urinary incontinence is likely underestimated, as many patients do not report their symptoms to healthcare providers for various reasons.<xref ref-type="bibr" rid="article-30850.r1">[1]</xref></p>
        <p>There are several types of urinary incontinence&#x02014;stress, urge, functional, mixed, and overflow incontinence. Initial evaluation typically does not require urologic or gynecologic assessment, but reversible causes should be ruled out. Management strategies depend on the type and severity of incontinence,&#x000a0;and the patient's discomfort and morbidity.<xref ref-type="bibr" rid="article-30850.r2">[2]</xref><xref ref-type="bibr" rid="article-30850.r1">[1]</xref></p>
      </sec>
      <sec id="article-30850.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The&#x000a0;5 types of urinary incontinence and their causes are as follows:<xref ref-type="bibr" rid="article-30850.r3">[3]</xref><xref ref-type="bibr" rid="article-30850.r2">[2]</xref></p>
        <p>
<bold>Stress Urinary Incontinence</bold>
</p>
        <p>Stress urinary incontinence is the involuntary leakage of urine that occurs with increased intra-abdominal pressure during activities such as exertion, straining, Valsalva, sneezing, or coughing due to the urethral sphincter weakness, pelvic floor weakness, or urethral hypermobility. Young women active in sports may experience this type of incontinence.<xref ref-type="bibr" rid="article-30850.r4">[4]</xref>&#x000a0;In addition, pregnant women and women who have experienced childbirth may be prone to stress urinary incontinence. Stress incontinence in men is typically a complication of prostate surgery, resulting in sphincteric insufficiency.&#x000a0;Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/29543">Stress Incontinence</ext-link>," for further information.</p>
        <p>
<bold>Urge Incontinence</bold>
</p>
        <p>Urge incontinence is the involuntary leakage of urine that may be preceded or accompanied by a sense of urinary urgency (but can be asymptomatic as well) due to detrusor overactivity. The contractions may be caused by bladder irritation or loss of neurologic control. The condition may be caused by detrusor instability, overactive bladder, or neurological conditions such as&#x000a0;stroke, Parkinson disease, or multiple sclerosis.&#x000a0;Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/87801">Urge Incontinence</ext-link>," for further information.</p>
        <p>
<bold>Mixed Urinary Incontinence</bold>
</p>
        <p>Mixed&#x000a0;urinary incontinence is the involuntary leakage of urine caused by a combination of stress and urge urinary incontinence, as described above. Typically, either urge or stress incontinence&#x000a0;is more predominant or bothersome.&#x000a0;Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/25209">Mixed Urinary Incontinence</ext-link>," for&#x000a0;additional information.</p>
        <p>
<bold>Overflow Urinary Incontinence</bold>
</p>
        <p>Overflow&#x000a0;urinary incontinence is the involuntary leakage of urine&#x000a0;from an overdistended bladder due to impaired detrusor contractility and bladder outlet obstruction. Neurologic diseases such as spinal cord injuries, multiple sclerosis, and diabetes can impair detrusor function, resulting in a hypotonic neurogenic bladder. Bladder outlet obstruction can be caused by external compression by abdominal or pelvic masses, urethral strictures, and pelvic organ prolapse, among other causes. A common&#x000a0;etiology in men is benign prostatic hyperplasia.</p>
        <p>Overflow urinary incontinence&#x000a0;is the only type of urinary incontinence considered directly physically dangerous, as it can lead to renal failure and permanent bladder damage. Please see StatPearls' companion resources, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/38803">Female Urinary Retention</ext-link>" and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/30854">Male Urinary Retention: Acute and Chronic</ext-link>," for further information.</p>
        <p>
<bold>Functional Urinary Incontinence</bold>
</p>
        <p>Functional&#x000a0;urinary incontinence is the involuntary leakage of urine due to environmental or physical barriers to toileting. This type of incontinence is sometimes referred to as toileting difficulty.</p>
      </sec>
      <sec id="article-30850.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Accurate prevalence data&#x000a0;are difficult to obtain due to underreporting, differing&#x000a0;definitions for urinary incontinence, and varying study designs.<xref ref-type="bibr" rid="article-30850.r5">[5]</xref><xref ref-type="bibr" rid="article-30850.r6">[6]</xref>&#x000a0;However, it&#x000a0;is estimated that&#x000a0;approximately&#x000a0;423 million individuals aged 20 or older worldwide experience some form of urinary incontinence (see <bold>Image.</bold>&#x000a0;Types of Urinary Incontinence by Age Bands).<xref ref-type="bibr" rid="article-30850.r7">[7]</xref>&#x000a0;</p>
        <p>In the United States, approximately 13 million individuals&#x000a0;are directly affected by urinary incontinence. The prevalence is 50% or greater among residents of nursing facilities and rises to more than 75% among long-term (&#x0003e;100 days) residents.<xref ref-type="bibr" rid="article-30850.r8">[8]</xref><xref ref-type="bibr" rid="article-30850.r9">[9]</xref>&#x000a0;Caregivers report that 53% of the homebound&#x000a0;older individuals are incontinent. A random sampling of hospitalized&#x000a0;older patients reports that 11% of patients have persistent urinary incontinence at admission and 23% at discharge.<xref ref-type="bibr" rid="article-30850.r6">[6]</xref></p>
        <p>Approximately 24% to 45% of women reported urinary incontinence. Among women aged 20 to 39, 7% to 37% experience some degree of incontinence. In<bold>&#x000a0;</bold>women older than&#x000a0;60, approximately&#x000a0;9% to 39%&#x000a0;reported urinary incontinence on a daily basis. An increased risk of urinary incontinence is associated with pregnancy, childbirth, diabetes, and increased body mass index.</p>
        <p>The overall prevalence of incontinence in men is about half that of women.<xref ref-type="bibr" rid="article-30850.r6">[6]</xref>&#x000a0;Urinary incontinence is reported in 11% to 34% of older men, with 2% to 11% reporting daily occurrences. Increased risk is associated with prostate surgery.<xref ref-type="bibr" rid="article-30850.r5">[5]</xref>&#x000a0;</p>
        <p>The estimated overall prevalence for&#x000a0;specific types of urinary incontinence is as follows:<xref ref-type="bibr" rid="article-30850.r2">[2]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Stress urinary incontinence: 24% to 45% in women older than 30</p>
          </list-item>
          <list-item>
            <p>Urge&#x000a0;urinary incontinence: 9% in women aged 40 to 44, 31% in women&#x000a0;older than 75, 42% in men&#x000a0;older than 75 years</p>
          </list-item>
          <list-item>
            <p>Mixed&#x000a0;urinary incontinence: 20% to 30% of those with chronic incontinence</p>
          </list-item>
          <list-item>
            <p>Overflow&#x000a0;urinary incontinence: 5% of those with chronic incontinence</p>
          </list-item>
          <list-item>
            <p>Functional&#x000a0;urinary incontinence: uncertain&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
        </list>
        <p>Among adult women in the United States (approximately 80 million individuals), over 60% report some degree of urinary incontinence, with&#x000a0;one-third experiencing leakage at least monthly.<xref ref-type="bibr" rid="article-30850.r10">[10]</xref> The most common incontinence type reported was stress (37.5%), followed by mixed (31.3%) and urge incontinence (22%).<xref ref-type="bibr" rid="article-30850.r10">[10]</xref></p>
      </sec>
      <sec id="article-30850.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A thorough history and physical examination are essential in evaluating patients with urinary incontinence. This comprehensive assessment helps identify the underlying causes, differentiate between types of incontinence, and guide appropriate management strategies.</p>
        <p>
<bold>History</bold>
</p>
        <p>The history should be used to determine the type, severity, burden, and duration of urinary incontinence. Voiding diaries may help provide details about episodes of incontinence. Signs and symptoms of emergent conditions, such as cauda equina syndrome, and reversible causes should be investigated.</p>
        <p>The history can often determine the type of urinary incontinence:</p>
        <list list-type="bullet">
          <list-item>
            <p>Stress urinary incontinence:&#x000a0;Patients can generally predict the inciting activity, typically laughing, coughing, abdominal straining, or sneezing.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Urge&#x000a0;urinary incontinence: Frequency, urgency, and nocturia may be present. There is variable volume loss, ranging from almost nothing to flooding. Bladder post-void residual urine volume is typically low.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Mixed&#x000a0;urinary incontinence: There are characteristics of both stress and urge incontinence. This type helps determine which component is most predominant or bothersome.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Overflow&#x000a0;urinary incontinence: This condition is associated with poor bladder emptying or urinary retention in both men and women.&#x000a0;Post-void residual urine volume is typically very high, and the patient may&#x000a0;note the need to strain. Please see StatPearls' companion resources, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/38803">Female Urinary Retention</ext-link>" and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/30854">Male Urinary Retention: Acute and Chronic</ext-link>," for more information.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Functional&#x000a0;urinary incontinence: The history may suggest physical or cognitive impairment.</p>
          </list-item>
        </list>
        <p>The&#x000a0;3 incontinence questions is a brief questionnaire that may be useful to distinguish among stress, urge, mixed urinary incontinence, and other causes. The 3 incontinence questions predict stress urinary incontinence with a specificity of up to 92%, but its utility may depend on the population studied.<xref ref-type="bibr" rid="article-30850.r11">[11]</xref><xref ref-type="bibr" rid="article-30850.r12">[12]</xref></p>
        <p>Patients should be asked about medical conditions such as chronic obstructive pulmonary disease and asthma, which can cause cough; heart failure, with related fluid overload and diuresis; neurologic conditions, which may suggest dysregulated bladder innervation; and musculoskeletal conditions, which may contribute to toileting barriers.</p>
        <p>Surgical history should also be assessed as&#x000a0;the anatomy and innervation involved may have been affected by prior surgeries. Male stress incontinence, for example, is almost always due to postoperative complications from urologic surgery. Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/160040">Slings for Male Incontinence</ext-link>," for further information.</p>
        <p>For females, obtaining a gynecologic history should be obtained to assess the number of births, mode of deliveries (vaginal or Cesarean section), and current pregnancy status. In addition, estrogen status should be determined as atrophic vaginitis and urethritis may contribute to reversible urinary incontinence during perimenopause.</p>
        <p>Patients should be asked about their medication and substance use, such as diuretics, alcohol, and caffeine, as they can either directly or indirectly contribute to incontinence. Potential adverse effects include impaired cognition, alteration of bladder tone or sphincter function, cough induction, and promotion of diuresis.</p>
        <p>Symptom severity and patient therapeutic preferences are ascertained, along with possible surgical tolerance and acceptability, to determine the appropriate degree of treatment aggressiveness.<xref ref-type="bibr" rid="article-30850.r2">[2]</xref><xref ref-type="bibr" rid="article-30850.r13">[13]</xref></p>
        <p>
<bold>Physical Examination</bold>
</p>
        <p>A thorough patient&#x000a0;history should guide the&#x000a0;clinician toward an appropriate physical examination. Emergent conditions and reversible causes should be explored.&#x000a0;</p>
        <p>Components and findings of Physical examination that should be assessed, if appropriate, include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cardiovascular: Pedal edema and jugular venous distension</p>
          </list-item>
          <list-item>
            <p>Pulmonary: Pulmonary crackles and cough</p>
          </list-item>
          <list-item>
            <p>Abdominal: Masses and surgical scars</p>
          </list-item>
          <list-item>
            <p>Genitourinary/rectal: Bladder distension, vaginal atrophy, pelvic organ prolapse, prostatic hypertrophy, fecal impaction, and rectal tone</p>
          </list-item>
          <list-item>
            <p>Musculoskeletal: Extremity strength, range of motion, and overall function</p>
          </list-item>
          <list-item>
            <p>Neurologic: Cognitive function, sensation, and reflexes&#x000a0;<xref ref-type="bibr" rid="article-30850.r2">[2]</xref><xref ref-type="bibr" rid="article-30850.r13">[13]</xref></p>
          </list-item>
        </list>
        <p>Optional tests and maneuvers to consider are as follows:</p>
        <p>Cough stress test: The patient is asked to cough to demonstrate the involuntary leakage of urine. The test is more sensitive when performed in a standing&#x000a0;position.<xref ref-type="bibr" rid="article-30850.r13">[13]</xref>&#x000a0;A Valsalva urinary stress test is similar.</p>
        <p>Cotton swab test:<bold>&#x000a0;</bold>The female patient is asked to Valsalva after insertion of a lubricated cotton swab placed just into the bladder through the urethra to demonstrate the degree of urethral hypermobility (associated with stress urinary incontinence), with an angle change &#x0003e;30&#x000b0; being&#x000a0;a positive result. There may be poor agreement of the test result when the angle is from 21&#x000b0; to 49&#x000b0;.<xref ref-type="bibr" rid="article-30850.r14">[14]</xref></p>
        <p>Pediatric Foley catheter test: This test is used to screen for intrinsic sphincteric deficiency, a subtype of stress incontinence. An 8-French pediatric Foley catheter is placed in the bladder, the balloon is inflated, and the catheter is gently withdrawn. If the catheter, with its bulb inflated, can be easily extracted from the urethra, the test is positive, suggesting intrinsic sphincteric deficiency.<xref ref-type="bibr" rid="article-30850.r15">[15]</xref>&#x000a0;This diagnosis is confirmed if the cotton swab test is negative, indicating no urethral hypermobility.<xref ref-type="bibr" rid="article-30850.r15">[15]</xref></p>
      </sec>
      <sec id="article-30850.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The evaluation of urinary incontinence should include a&#x000a0;focused but detailed history and thorough physical examination. Potentially reversible causes, including abnormal sleep patterns, fluid overload, misuse of diuretics, and similar entities, should be identified. Medication reconciliation should be carried out, and comorbidities should be determined.<xref ref-type="bibr" rid="article-30850.r2">[2]</xref><xref ref-type="bibr" rid="article-30850.r13">[13]</xref><xref ref-type="bibr" rid="article-30850.r16">[16]</xref>&#x000a0;Minimal laboratory testing or imaging is required for evaluation. Most laboratory and diagnostic tests are used to rule out other harmful conditions and sequelae.<xref ref-type="bibr" rid="article-30850.r2">[2]</xref><xref ref-type="bibr" rid="article-30850.r13">[13]</xref><xref ref-type="bibr" rid="article-30850.r16">[16]</xref></p>
        <p>Urinalysis should be performed on all patients to assess for urinary tract infection, glycosuria, proteinuria, and hematuria. A urine culture is indicated in all cases suspected of an infection. Serum blood urea nitrogen and creatinine should be performed to assess renal function if an obstruction is suspected.</p>
        <p>Post-void residual volume should be evaluated, particularly if overflow urinary incontinence is suspected. A bladder ultrasound is performed after a patient voids, either as a formal ultrasound examination or by a dedicated bladder ultrasonic scanner. Detection of &#x0003e;200 mL of urine remaining in the bladder after voiding&#x000a0;suggests overflow urinary incontinence and possible bladder hypotonicity.&#x000a0;High post-void residuals suggest inadequate emptying, hypotonic bladder function, and possible overflow incontinence.&#x000a0;Low post-void residuals are more common with urge incontinence and overactive bladder symptoms. Please see StatPearls' companion resource,&#x000a0;"<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/27473">Bladder Post Void Residual Volume</ext-link>," for more information.</p>
        <p>A 24-hour or 3-day voiding diary may be helpful in selected cases.<xref ref-type="bibr" rid="article-30850.r17">[17]</xref><xref ref-type="bibr" rid="article-30850.r18">[18]</xref> The patient is instructed to write down and record the time and the amount of urine voided in mL for at least a full 24 hours. Overactive bladder patients tend to void in small volumes frequently throughout the entire period. Patients with global polyuria have relatively large voided urine volumes throughout the day and night, with very large total volumes. A normal 24-hour urine total volume is about 1300 mL. More than 3000 mL is considered polyuria.</p>
        <p>A 24-hour pad test is used to assess the severity of urinary incontinence&#x000a0;in selected patients and can also be repeated to track the success of treatment. Weighed pads are used by the patient until they become soaked or at 6 hours. They are weighed again when changed, and the difference between the 2 weights represents the amount of urine leaked. Mild incontinence is up to 20 g, 21 to 74 g is moderate, and 75 g or more is considered severe.<xref ref-type="bibr" rid="article-30850.r19">[19]</xref><xref ref-type="bibr" rid="article-30850.r20">[20]</xref></p>
        <p>A renal ultrasound should be considered to assess hydronephrosis in cases of suspected&#x000a0;obstruction and in patients with renal failure. Urodynamic testing is unnecessary except for complicated (intractable) cases or if surgery is being considered.<xref ref-type="bibr" rid="article-30850.r21">[21]</xref>&#x000a0;Please see StatPearls' companion resource,&#x000a0;"<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/106752">Urodynamic Testing and Interpretation</ext-link>," for more information.</p>
      </sec>
      <sec id="article-30850.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment and management of urinary incontinence&#x000a0;depends on its&#x000a0;type. Conservative, pharmacologic, and surgical treatment modalities exist.&#x000a0;Medications should be reconciled, and substances such as caffeine and alcohol should be avoided if they are contributing to the patient's incontinence. Treatment should begin with the least invasive methods&#x000a0;and then escalate as appropriate.<xref ref-type="bibr" rid="article-30850.r2">[2]</xref><xref ref-type="bibr" rid="article-30850.r13">[13]</xref><xref ref-type="bibr" rid="article-30850.r22">[22]</xref></p>
        <p>Type-specific treatment strategies include the following:</p>
        <p>
<bold>Stress Urinary Incontinence</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Conservative management: Behavioral therapy, including controlling fluid intake, prompted voiding, bladder training, and constipation management; electrical stimulation; mechanical devices, such as cones, pessaries, and urethral plugs; physical therapy; biofeedback; pelvic floor muscle strengthening, such as Kegel and floor muscle exercises; weight loss; pads, such as diapers; condom catheters; and dietary adjustments, such as eliminating caffeine and other irritants.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pharmacologic&#x000a0;management: Alpha-adrenergic agonists, such as phenylpropanolamine; duloxetine (not FDA-approved; imipramine; vaginal estrogen cream; and overactive bladder pharmaceutical agents as appropriate.<xref ref-type="bibr" rid="article-30850.r23">[23]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Surgical&#x000a0;management: Trans- or periurethral injections of bulking agents, sling procedures, urethropexy, implantable dual-balloon adjustable continence device, and artificial sphincters.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Please see StatPearls' companion resources, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/29543">Stress Incontinence</ext-link>," "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/160040">Slings for Male Incontinence</ext-link>," and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/151840">Artificial Urinary Sphincters and Adjustable Dual-Balloon Continence Therapy in Men</ext-link>," for further information.</p>
          </list-item>
        </list>
        <p>
<bold>Urge Urinary Incontinence</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Conservative&#x000a0;management: Similar to the treatment for stress urinary incontinence with the exception of mechanical devices.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pharmacologic&#x000a0;management: Antimuscarinics, such as darifenacin, solifenacin, oxybutynin, tolterodine, fesoterodine, and trospium;<xref ref-type="bibr" rid="article-30850.r24">[24]</xref>&#x000a0;topical vaginal estrogen (not FDA-approved); mirabegron; vibegron; and imipramine.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Surgical&#x000a0;management: Sacral neuromodulation, tibial nerve stimulation, onabotulinum toxin A bladder injections, and augmentation cystoplasty.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Please see StatPearls' companion resources, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/87801">Urge Incontinence</ext-link>" and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/127382">Sacral Neuromodulation</ext-link>," for further information.</p>
          </list-item>
        </list>
        <p>
<bold>Mixed Urinary Incontinence</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>As mentioned above, treatment and management focus on the most dominant symptoms.</p>
          </list-item>
          <list-item>
            <p>Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/25209">Mixed Urinary Incontinence,</ext-link>" for further information.</p>
          </list-item>
        </list>
        <p>
<bold>Overflow Urinary Incontinence</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Conservative&#x000a0;management: Clean intermittent catheterization, indwelling urethral catheter, and relief of obstruction.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pharmacologic&#x000a0;management: Bethanechol, a detrusor stimulant, and alpha-adrenergic antagonists, such as doxazosin, terazosin, tamsulosin.<xref ref-type="bibr" rid="article-30850.r23">[23]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Surgical&#x000a0;management: Suprapubic catheter and transurethral prostate resection, if detrusor muscle tone is sufficient and capable of generating at least 30 to 35 cm of water pressure.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Please see StatPearls' companion resources, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/www.statpearls.com/point-of-">Female Urinary Retention</ext-link>" and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/30854">Male Urinary Retention: Acute and Chronic</ext-link>," for further information.</p>
          </list-item>
        </list>
        <p>
<bold>Functional Urinary Incontinence</bold>
</p>
        <p>Underlying causes should be addressed and alleviated if possible.</p>
      </sec>
      <sec id="article-30850.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Establishing a differential diagnosis for urinary incontinence is crucial for identifying the specific type and underlying cause of the condition. This process involves distinguishing between various forms of incontinence, such as stress, urge, overflow, and functional incontinence,&#x000a0;and ruling out other potential medical issues. A thorough differential diagnosis ensures appropriate and targeted treatment for each patient.</p>
        <p>The mnemonic DIAPPERS can be used as an aid&#x000a0;to develop a differential diagnosis for reversible causes of urinary incontinence:</p>
        <list list-type="bullet">
          <list-item>
            <p>Delirium, dementia, or other cognitive impairments</p>
          </list-item>
          <list-item>
            <p>Infection (urinary tract infection)</p>
          </list-item>
          <list-item>
            <p>Atrophic vaginitis or urethritis</p>
          </list-item>
          <list-item>
            <p>Pharmaceuticals or substances, such as diuretics, caffeine, and alcohol</p>
          </list-item>
          <list-item>
            <p>Psychological disorder</p>
          </list-item>
          <list-item>
            <p>Excessive urine output, such as diabetes and diabetes insipidus</p>
          </list-item>
          <list-item>
            <p>Reduced mobility or reversible urinary retention</p>
          </list-item>
          <list-item>
            <p>Stool impaction&#x000a0;<xref ref-type="bibr" rid="article-30850.r2">[2]</xref></p>
          </list-item>
        </list>
        <p>Other conditions to consider include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Anatomic abnormalities such as urogenital fistulas, diverticula, renal duplication, and ectopic ureters (though these are less common)</p>
          </list-item>
          <list-item>
            <p>Hydronephrosis</p>
          </list-item>
          <list-item>
            <p>Intra-abdominal or&#x000a0;pelvic mass</p>
          </list-item>
          <list-item>
            <p>Interstitial cystitis</p>
          </list-item>
          <list-item>
            <p>Neurologic conditions such as spinal cord injuries, cauda equina syndrome, multiple sclerosis, cerebral vascular accidents, normal pressure hydrocephalus, spinal stenosis, Parkinson disease, and diabetic neuropathy</p>
          </list-item>
          <list-item>
            <p>Pelvic organ prolapse</p>
          </list-item>
          <list-item>
            <p>Polyuria</p>
          </list-item>
          <list-item>
            <p>Urinary tract infection</p>
          </list-item>
          <list-item>
            <p>Urolithiasis (especially distal ureteral calculi)</p>
          </list-item>
          <list-item>
            <p>Vesicoureteral reflux&#x000a0;<xref ref-type="bibr" rid="article-30850.r25">[25]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30850.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Response to treatment and management varies among patients.&#x000a0;For those&#x000a0;whose symptoms cannot be eliminated, optimal symptom control should be sought by multiple treatment modalities. Median cure rates for stress, urge, and mixed urinary incontinence by select modalities are as follows:<xref ref-type="bibr" rid="article-30850.r26">[26]</xref></p>
        <p>
<bold>Stress Urinary Incontinence</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>58.8% at 12 months for women who used supervised pelvic floor muscle training.</p>
          </list-item>
          <list-item>
            <p>78% at 6 months for men that used pelvic floor muscle training.</p>
          </list-item>
          <list-item>
            <p>84.4% at 12 months for women who&#x000a0;received&#x000a0;surgical interventions.</p>
          </list-item>
          <list-item>
            <p>50% of patients who received an artificial urinary sphincter have complete continence after 5 years, whereas another 40% can&#x000a0;manage with only 1 pad per day. Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/151840">Artificial Urinary Sphincters and Adjustable Dual-Balloon Continence Therapy in Men</ext-link>," for further information.</p>
          </list-item>
          <list-item>
            <p>55% of patients who received a dual-balloon adjustable continence device reported long-term cures or substantially reduced leakage. Please see StatPearls' companion resource,&#x000a0;"<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/151840">Artificial Urinary Sphincters and Adjustable Dual-Balloon Continence Therapy in Men</ext-link>," for further information.</p>
          </list-item>
          <list-item>
            <p>75% of properly selected men who received a sling indicated a cure or a substantial improvement in their stress urinary incontinence. Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/160040">Slings for Male Incontinence</ext-link>,"&#x000a0;for further information.</p>
          </list-item>
          <list-item>
            <p>53% after 3 years for males who received slings.</p>
          </list-item>
        </list>
        <p>
<bold>Urge Urinary Incontinence</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>49% at 12 months for women who used antimuscarinics.</p>
          </list-item>
          <list-item>
            <p>15.9% to 50.9% at 3 months in women who used onabotulinum toxin A.</p>
          </list-item>
          <list-item>
            <p>17% at 10 years for women who used sacral neuromodulation.</p>
          </list-item>
          <list-item>
            <p>24% to 35% at 12 months for men who used supervised pelvic floor muscle training.</p>
          </list-item>
        </list>
        <p>
<bold>Mixed Urinary Incontinence</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>28% at 6 months for women with supervised pelvic floor muscle training.</p>
          </list-item>
          <list-item>
            <p>47% of men who used supervised pelvic floor muscle training.</p>
          </list-item>
          <list-item>
            <p>82.3% of women who received&#x000a0;surgical interventions.</p>
          </list-item>
        </list>
        <p>Several inventories and tools may be used to monitor symptoms and treatment effectiveness.</p>
        <list list-type="bullet">
          <list-item>
            <p>Michigan incontinence symptom index (M-ISI): This questionnaire assesses the frequency of urinary incontinence, the amount of protection used, and the impact of urinary incontinence on daily activities.<xref ref-type="bibr" rid="article-30850.r27">[27]</xref></p>
          </list-item>
          <list-item>
            <p>International consultation on incontinence questionnaire form (ICIQ-UI short form): This questionnaire has high&#x000a0;intra- and interobserver reliability.<xref ref-type="bibr" rid="article-30850.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <p>Sandvik questionnaire (incontinence severity index): This questionnaire assesses the frequency and amount of leakage and is highly correlated with the ICIQ-UI short form.<xref ref-type="bibr" rid="article-30850.r29">[29]</xref></p>
          </list-item>
          <list-item>
            <p>24-hour pad test.<xref ref-type="bibr" rid="article-30850.r19">[19]</xref><xref ref-type="bibr" rid="article-30850.r20">[20]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30850.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Urinary incontinence can lead to many complications that significantly impact a patient's health and quality of life. These complications range from physical issues, such as skin infections and urinary tract infections, to psychological effects, including anxiety and depression. In addition, the condition can cause social isolation and decreased mobility. Understanding the complete scope of complications is crucial for comprehensive patient care.</p>
        <p>The complications associated with urinary incontinence include the following:<xref ref-type="bibr" rid="article-30850.r13">[13]</xref><xref ref-type="bibr" rid="article-30850.r23">[23]</xref><xref ref-type="bibr" rid="article-30850.r30">[30]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Cellulitis</p>
          </list-item>
          <list-item>
            <p>Decreased physical activity and libido</p>
          </list-item>
          <list-item>
            <p>Depression</p>
          </list-item>
          <list-item>
            <p>Increased caregiver burden</p>
          </list-item>
          <list-item>
            <p>Increased risk of falls and subsequent fractures</p>
          </list-item>
          <list-item>
            <p>Mechanical failure (leak)</p>
          </list-item>
          <list-item>
            <p>Medication&#x000a0;adverse effects&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;
<list list-type="bullet"><list-item><p>Alpha-adrenergic agonists: Dry mouth, restlessness, hypertension, and insomnia.<xref ref-type="bibr" rid="article-30850.r23">[23]</xref>&#x000a0;Please see StatPearls' companion resource,&#x000a0;"<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/17240">Adrenergic Drugs</ext-link>," for more information.</p></list-item><list-item><p>Alpha-adrenergic antagonists: Hypotension, dizziness, fatigue, and sedation.<xref ref-type="bibr" rid="article-30850.r31">[31]</xref>&#x000a0;Please see StatPearls' companion resources,&#x000a0;"<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/17401">Alpha-Blockers</ext-link>" and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/27115">Phenoxybenzamine</ext-link>," for more information.</p></list-item><list-item><p>Antimuscarinics: Dry mouth, constipation, blurred vision, dry eyes, fatigue, difficulty in micturition, and palpitations.<xref ref-type="bibr" rid="article-30850.r26">[26]</xref>&#x000a0;Please see StatPearls' companion resource,&#x000a0;"<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/25379">Muscarinic Antagonists</ext-link>," for more information.</p></list-item><list-item><p>Duloxetine: Dry mouth, nausea, fatigue, constipation, and hyperhidrosis.<xref ref-type="bibr" rid="article-30850.r31">[31]</xref>&#x000a0;Please see StatPearls' companion resource,&#x000a0;"<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/20751">Duloxetine</ext-link>," for more information.</p></list-item><list-item><p>Mirabegron and vibegron: Urinary tract infections and hypertension.<xref ref-type="bibr" rid="article-30850.r30">[30]</xref><xref ref-type="bibr" rid="article-30850.r32">[32]</xref>&#x000a0;Please see StatPearls' companion resource,&#x000a0;"<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/38808">Mirabegron</ext-link>," for more information.</p></list-item><list-item><p>Onabotulinumtoxin A injection: Urinary tract infections and urinary retention&#x000a0;<xref ref-type="bibr" rid="article-30850.r31">[31]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Pressure ulcers</p>
          </list-item>
          <list-item>
            <p>Renal dysfunction secondary to obstructive uropathy</p>
          </list-item>
          <list-item>
            <p>Sexual dysfunction</p>
          </list-item>
          <list-item>
            <p>Social isolation</p>
          </list-item>
          <list-item>
            <p>Trauma and infection due to catheterization</p>
          </list-item>
          <list-item>
            <p>Treatment failure</p>
          </list-item>
          <list-item>
            <p>Urethral erosion</p>
          </list-item>
          <list-item>
            <p>Urinary tract infections</p>
          </list-item>
          <list-item>
            <p>Worsening of urinary incontinence after&#x000a0;surgical intervention</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30850.s11" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consultations play a vital role in effectively managing urinary incontinence, ensuring comprehensive care tailored to individual patient needs. These consultations involve specialists such as urologists, gynecologists, and geriatricians, who provide expertise in diagnosing the type and severity of incontinence. They also guide personalized treatment plans, incorporating both conservative and surgical interventions when necessary to improve patient outcomes and quality of life.</p>
        <p>Further evaluation is warranted and recommended in the following situations:<xref ref-type="bibr" rid="article-30850.r2">[2]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Incontinence associated with relapse</p>
          </list-item>
          <list-item>
            <p>Incontinence associated with recurrent symptomatic urinary tract infections</p>
          </list-item>
          <list-item>
            <p>Incontinence with new-onset neurologic symptoms</p>
          </list-item>
          <list-item>
            <p>Marked prostate enlargement</p>
          </list-item>
          <list-item>
            <p>Neurogenic bladder</p>
          </list-item>
          <list-item>
            <p>Pelvic organ prolapsed past the introitus</p>
          </list-item>
          <list-item>
            <p>Pelvic pain associated with incontinence</p>
          </list-item>
          <list-item>
            <p>Persistent or unexplained hematuria</p>
          </list-item>
          <list-item>
            <p>Persistent proteinuria</p>
          </list-item>
          <list-item>
            <p>Postvoid residual volume &#x0003e;200 mL</p>
          </list-item>
          <list-item>
            <p>Previous pelvic surgery or radiation</p>
          </list-item>
          <list-item>
            <p>Spinal cord injury</p>
          </list-item>
          <list-item>
            <p>Surgical complication</p>
          </list-item>
          <list-item>
            <p>Treatment failure</p>
          </list-item>
          <list-item>
            <p>Uncertain diagnosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30850.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Deterrence and patient education are crucial in effectively addressing urinary incontinence. Patients and their families should be informed that although urinary incontinence is highly prevalent in older adults, it is not a normal part of aging. They should be aware that many causes of urinary incontinence are reversible, and all cases are treatable to some degree.</p>
        <p>Educating patients about risk factors such as obesity, chronic cough, and pelvic floor weakness can empower them to adopt preventive measures, including weight management and regular pelvic floor exercises. Patient education also encompasses understanding the types and causes of incontinence, managing fluid intake, and recognizing symptoms early.&#x000a0;Education about the various treatment and management options available, including conservative, pharmacologic, and surgical modalities, is essential.</p>
        <p>Promoting open communication encourages patients to seek timely medical advice, reducing stigma and promoting proactive management strategies. By emphasizing education and preventive measures, healthcare professionals can significantly enhance patient awareness and self-management of urinary incontinence.</p>
      </sec>
      <sec id="article-30850.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>In some cases, an incontinence system using a special pad and a bedside vacuum drainage system can provide symptomatic relief of wetness to bedridden patients even if the incontinence cannot be controlled.<xref ref-type="bibr" rid="article-30850.r33">[33]</xref><xref ref-type="bibr" rid="article-30850.r34">[34]</xref>&#x000a0;Male and female incontinence pads are available.</p>
        <p>Urinary incontinence in end-of-life care can be challenging to manage and should be handled on a case-by-case basis. In some instances, an indwelling catheter or condom catheter may be used to maximize patient comfort&#x000a0;during the last stages of life.</p>
      </sec>
      <sec id="article-30850.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Enhancing patient-centered care and outcomes related to urinary incontinence requires a collaborative approach involving physicians, advanced care practitioners, nurses, pharmacists, and other healthcare professionals<bold>.</bold> Clinicians need proficiency in comprehensive assessment skills to accurately diagnose and classify the type of urinary incontinence, ensuring tailored treatment plans. Strategic management involves integrating evidence-based practices with patient preferences and promoting shared decision-making and autonomy.</p>
        <p>Pharmacists can provide critical input and assist with medication reconciliation. They help minimize unwanted anticholinergic effects of patient medications and suggest dosage adjustments for patients with renal failure. In more complicated cases of urinary incontinence, collaboration among primary care clinicians and specialists is needed to deliver seamless, quality care to patients.&#x000a0;</p>
        <p>The responsibilities of the interprofessional healthcare team include ongoing education on the latest treatment modalities and patient education strategies, empowering individuals to actively participate in managing their condition. Interprofessional communication is crucial for cohesive care delivery, fostering teamwork, and reducing medical errors. Care coordination ensures seamless transitions between healthcare settings, optimizing continuity of care and patient safety.</p>
      </sec>
      <sec id="article-30850.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30850&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30850">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/kidney-health/urinary-incontinence/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30850">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30850/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30850">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-30850.s16">
        <fig id="article-30850.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Types of Urinary Incontinence by Age Bands. White, other; Green, urge; Light green, mixed; Red, stress. Hunskaar S, Lose G, Sykes D, Voss S. The prevalence of urinary incontinence in women in four European&#x000a0;countries.<italic toggle="yes">&#x000a0;BJU Int.</italic> 2004;93(3):324-330. doi: 10.1111/j.1464-410x.2003.04609.x.&#x000a0;</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="2020-06-07__x2x" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-30850.s17">
        <title>References</title>
        <ref id="article-30850.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lukacz</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Santiago-Lastra</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Albo</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Brubaker</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Urinary Incontinence in Women: A Review.</article-title>
            <source>JAMA</source>
            <year>2017</year>
            <month>Oct</month>
            <day>24</day>
            <volume>318</volume>
            <issue>16</issue>
            <fpage>1592</fpage>
            <page-range>1592-1604</page-range>
            <pub-id pub-id-type="pmid">29067433</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khandelwal</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kistler</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of urinary incontinence.</article-title>
            <source>Am Fam Physician</source>
            <year>2013</year>
            <month>Apr</month>
            <day>15</day>
            <volume>87</volume>
            <issue>8</issue>
            <fpage>543</fpage>
            <page-range>543-50</page-range>
            <pub-id pub-id-type="pmid">23668444</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abrams</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cardozo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fall</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Griffiths</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rosier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ulmsten</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Van Kerrebroeck</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Victor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wein</surname>
                <given-names>A</given-names>
              </name>
              <collab>Standardisation Sub-Committee of the International Continence Society</collab>
            </person-group>
            <article-title>The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.</article-title>
            <source>Urology</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>61</volume>
            <issue>1</issue>
            <fpage>37</fpage>
            <page-range>37-49</page-range>
            <pub-id pub-id-type="pmid">12559262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alves</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>Luz</surname>
                <given-names>STD</given-names>
              </name>
              <name>
                <surname>Brand&#x000e3;o</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Da Luz</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Jorge</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Da Roza</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Urinary Incontinence in Physically Active Young Women: Prevalence and Related Factors.</article-title>
            <source>Int J Sports Med</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>38</volume>
            <issue>12</issue>
            <fpage>937</fpage>
            <page-range>937-941</page-range>
            <pub-id pub-id-type="pmid">28950397</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buckley</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Lapitan</surname>
                <given-names>MC</given-names>
              </name>
              <collab>Epidemiology Committee of the Fourth International Consultation on Incontinence, Paris, 2008</collab>
            </person-group>
            <article-title>Prevalence of urinary incontinence in men, women, and children--current evidence: findings of the Fourth International Consultation on Incontinence.</article-title>
            <source>Urology</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>76</volume>
            <issue>2</issue>
            <fpage>265</fpage>
            <page-range>265-70</page-range>
            <pub-id pub-id-type="pmid">20541241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <article-title>Managing acute and chronic urinary incontinence. AHCPR Urinary Incontinence in Adults Guideline Update Panel.</article-title>
            <source>Am Fam Physician</source>
            <year>1996</year>
            <month>Oct</month>
            <volume>54</volume>
            <issue>5</issue>
            <fpage>1661</fpage>
            <page-range>1661-72</page-range>
            <pub-id pub-id-type="pmid">8857788</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Irwin</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Kopp</surname>
                <given-names>ZS</given-names>
              </name>
              <name>
                <surname>Agatep</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Milsom</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Abrams</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction.</article-title>
            <source>BJU Int</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>108</volume>
            <issue>7</issue>
            <fpage>1132</fpage>
            <page-range>1132-8</page-range>
            <pub-id pub-id-type="pmid">21231991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leung</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Schnelle</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Urinary and fecal incontinence in nursing home residents.</article-title>
            <source>Gastroenterol Clin North Am</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>697</fpage>
            <page-range>697-707, x</page-range>
            <pub-id pub-id-type="pmid">18794004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jerez-Roig</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Souza</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Amaral</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Lima</surname>
                <given-names>KC</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of urinary incontinence and associated factors in nursing home residents.</article-title>
            <source>Neurourol Urodyn</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>102</fpage>
            <page-range>102-7</page-range>
            <pub-id pub-id-type="pmid">25307780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>UJ</given-names>
              </name>
              <name>
                <surname>Godecker</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Giles</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>HW</given-names>
              </name>
            </person-group>
            <article-title>Updated Prevalence of Urinary Incontinence in Women: 2015-2018 National Population-Based Survey Data.</article-title>
            <source>Female Pelvic Med Reconstr Surg</source>
            <year>2022</year>
            <month>Apr</month>
            <day>01</day>
            <volume>28</volume>
            <issue>4</issue>
            <fpage>181</fpage>
            <page-range>181-187</page-range>
            <pub-id pub-id-type="pmid">35030139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brown</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Subak</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Richter</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Kraus</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Brubaker</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vittinghoff</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Grady</surname>
                <given-names>D</given-names>
              </name>
              <collab>Diagnostic Aspects of Incontinence Study (DAISy) Research Group</collab>
            </person-group>
            <article-title>The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence.</article-title>
            <source>Ann Intern Med</source>
            <year>2006</year>
            <month>May</month>
            <day>16</day>
            <volume>144</volume>
            <issue>10</issue>
            <fpage>715</fpage>
            <page-range>715-23</page-range>
            <pub-id pub-id-type="pmid">16702587</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khan</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Omar</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Laniado</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic agreement of the 3 Incontinence Questionnaire to video-urodynamics findings in women with urinary incontinence: Department of Urology, Frimley Health NHS Foundation Trust Wexham Park Hospital Slough, Berkshire, United Kingdom.</article-title>
            <source>Cent European J Urol</source>
            <year>2018</year>
            <volume>71</volume>
            <issue>1</issue>
            <fpage>84</fpage>
            <page-range>84-91</page-range>
            <pub-id pub-id-type="pmid">29732212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hu</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Pierre</surname>
                <given-names>EF</given-names>
              </name>
            </person-group>
            <article-title>Urinary Incontinence in Women: Evaluation and Management.</article-title>
            <source>Am Fam Physician</source>
            <year>2019</year>
            <month>Sep</month>
            <day>15</day>
            <volume>100</volume>
            <issue>6</issue>
            <fpage>339</fpage>
            <page-range>339-348</page-range>
            <pub-id pub-id-type="pmid">31524367</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Swift</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Herron</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goodnight</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Test-retest reliability of the cotton swab (Q-tip) test in the evaluation of the incontinent female.</article-title>
            <source>Int Urogynecol J</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>21</volume>
            <issue>8</issue>
            <fpage>963</fpage>
            <page-range>963-7</page-range>
            <pub-id pub-id-type="pmid">20379698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arya</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>ND</given-names>
              </name>
            </person-group>
            <article-title>Office screening test for intrinsic urethral sphincter deficiency: pediatric Foley catheter test.</article-title>
            <source>Obstet Gynecol</source>
            <year>2001</year>
            <month>Jun</month>
            <volume>97</volume>
            <issue>6</issue>
            <fpage>885</fpage>
            <page-range>885-9</page-range>
            <pub-id pub-id-type="pmid">11384690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <article-title>Committee Opinion No. 603: Evaluation of uncomplicated stress urinary incontinence in women before surgical treatment.</article-title>
            <source>Obstet Gynecol</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>123</volume>
            <issue>6</issue>
            <fpage>1403</fpage>
            <page-range>1403-1407</page-range>
            <pub-id pub-id-type="pmid">24848922</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khosla</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Farooq</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rychik</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Daniel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vizgan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Prishtina</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bushman</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Blaivas</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>The role of the bladder diary in phenotyping men with LUTS.</article-title>
            <source>Neurourol Urodyn</source>
            <year>2023</year>
            <month>Apr</month>
            <volume>42</volume>
            <issue>4</issue>
            <fpage>718</fpage>
            <page-range>718-724</page-range>
            <pub-id pub-id-type="pmid">36825401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bryan</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Chapple</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Frequency volume charts in the assessment and evaluation of treatment: how should we use them?</article-title>
            <source>Eur Urol</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>46</volume>
            <issue>5</issue>
            <fpage>636</fpage>
            <page-range>636-40</page-range>
            <pub-id pub-id-type="pmid">15474275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferreira</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>B&#x000f8;</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The Pad Test for urinary incontinence in women.</article-title>
            <source>J Physiother</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>61</volume>
            <issue>2</issue>
            <fpage>98</fpage>
            <pub-id pub-id-type="pmid">25744851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krhut</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zachoval</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Rosier</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Valansk&#x000fd;</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Martan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zvara</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Pad weight testing in the evaluation of urinary incontinence.</article-title>
            <source>Neurourol Urodyn</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>33</volume>
            <issue>5</issue>
            <fpage>507</fpage>
            <page-range>507-10</page-range>
            <pub-id pub-id-type="pmid">23797972</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fallon</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kreder</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Urodynamic assessment of sphincteric function in the incontinent female: which test, and does it matter anyway?</article-title>
            <source>Curr Urol Rep</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>7</volume>
            <issue>5</issue>
            <fpage>399</fpage>
            <page-range>399-404</page-range>
            <pub-id pub-id-type="pmid">16959179</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Subak</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Quesenberry</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Posner</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Cattolica</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Soghikian</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The effect of behavioral therapy on urinary incontinence: a randomized controlled trial.</article-title>
            <source>Obstet Gynecol</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>100</volume>
            <issue>1</issue>
            <fpage>72</fpage>
            <page-range>72-8</page-range>
            <pub-id pub-id-type="pmid">12100806</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Imam</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>The role of the primary care physician in the management of bladder dysfunction.</article-title>
            <source>Rev Urol</source>
            <year>2004</year>
            <volume>6 Suppl 1</volume>
            <issue>Suppl 1</issue>
            <fpage>S38</fpage>
            <page-range>S38-44</page-range>
            <pub-id pub-id-type="pmid">16985854</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gormley</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Lightner</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Burgio</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Chai</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Clemens</surname>
                <given-names>JQ</given-names>
              </name>
              <name>
                <surname>Culkin</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Scarpero</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Tessier</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Vasavada</surname>
                <given-names>SP</given-names>
              </name>
              <collab>American Urological Association</collab>
              <collab>Society of Urodynamics, Female Pelvic Medicine &#x00026; Urogenital Reconstruction</collab>
            </person-group>
            <article-title>Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline.</article-title>
            <source>J Urol</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>188</volume>
            <issue>6 Suppl</issue>
            <fpage>2455</fpage>
            <page-range>2455-63</page-range>
            <pub-id pub-id-type="pmid">23098785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morhason-Bello</surname>
                <given-names>IO</given-names>
              </name>
              <name>
                <surname>Adebayo</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Abdusalam</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Bello</surname>
                <given-names>OO</given-names>
              </name>
              <name>
                <surname>Odubamowo</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Lawal</surname>
                <given-names>OO</given-names>
              </name>
              <name>
                <surname>Olapade-Olaopa</surname>
                <given-names>EO</given-names>
              </name>
              <name>
                <surname>Ojengbede</surname>
                <given-names>OA</given-names>
              </name>
            </person-group>
            <article-title>Bilateral double ureters with bladder neck diverticulum in a nigerian woman masquerading as an obstetric fistula.</article-title>
            <source>Case Rep Urol</source>
            <year>2014</year>
            <volume>2014</volume>
            <fpage>801063</fpage>
            <pub-id pub-id-type="pmid">25587483</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Riemsma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hagen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kirschner-Hermanns</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Norton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wijk</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Andersson</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Chapple</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Spinks</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wagg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hutt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Misso</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Deshpande</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kleijnen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Milsom</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Can incontinence be cured? A systematic review of cure rates.</article-title>
            <source>BMC Med</source>
            <year>2017</year>
            <month>Mar</month>
            <day>24</day>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <pub-id pub-id-type="pmid">28335792</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suskind</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>DeLancey</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>McGuire</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>The Michigan Incontinence Symptom Index (M-ISI): a clinical measure for type, severity, and bother related to urinary incontinence.</article-title>
            <source>Neurourol Urodyn</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>33</volume>
            <issue>7</issue>
            <fpage>1128</fpage>
            <page-range>1128-34</page-range>
            <pub-id pub-id-type="pmid">23945994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hajebrahimi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Corcos</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lemieux</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>International consultation on incontinence questionnaire short form: comparison of physician versus patient completion and immediate and delayed self-administration.</article-title>
            <source>Urology</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>63</volume>
            <issue>6</issue>
            <fpage>1076</fpage>
            <page-range>1076-8</page-range>
            <pub-id pub-id-type="pmid">15183953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klovning</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Avery</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sandvik</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hunskaar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Comparison of two questionnaires for assessing the severity of urinary incontinence: The ICIQ-UI SF versus the incontinence severity index.</article-title>
            <source>Neurourol Urodyn</source>
            <year>2009</year>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>411</fpage>
            <page-range>411-5</page-range>
            <pub-id pub-id-type="pmid">19214996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stickley</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Santini</surname>
                <given-names>ZI</given-names>
              </name>
              <name>
                <surname>Koyanagi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Urinary incontinence, mental health and loneliness among community-dwelling older adults in Ireland.</article-title>
            <source>BMC Urol</source>
            <year>2017</year>
            <month>Apr</month>
            <day>08</day>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <pub-id pub-id-type="pmid">28388898</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Demaagd</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Davenport</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>Management of urinary incontinence.</article-title>
            <source>P T</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>37</volume>
            <issue>6</issue>
            <fpage>345</fpage>
            <page-range>345-361H</page-range>
            <pub-id pub-id-type="pmid">22876096</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chapple</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Cardozo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nitti</surname>
                <given-names>VW</given-names>
              </name>
              <name>
                <surname>Siddiqui</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Michel</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability.</article-title>
            <source>Neurourol Urodyn</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-30</page-range>
            <pub-id pub-id-type="pmid">24127366</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khosla</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sani</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Chughtai</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Patient and caretaker satisfaction with the PureWick system.</article-title>
            <source>Can J Urol</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>11216</fpage>
            <page-range>11216-11223</page-range>
            <pub-id pub-id-type="pmid">35969725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30850.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bagley</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Severud</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Preventing Catheter-Associated Urinary Tract Infections with Incontinence Management Alternatives: PureWick and Condom Catheter.</article-title>
            <source>Nurs Clin North Am</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>56</volume>
            <issue>3</issue>
            <fpage>413</fpage>
            <page-range>413-425</page-range>
            <pub-id pub-id-type="pmid">34366161</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
